Yael Haberman Ziv, MD, PhD

Baseline terminal ileal CT and MRI measurements are associated with imaging outcomes in pediatric Crohn's disease: a cohort study. Ta, AD; Dillman, JR; Ollberding, NJ; Haberman, Y; Baldassano, R; Markowitz, J; Otley, A; Dotson, JL; Pfefferkorn, M; Hyams, JS; Snapper, S; Alazraki, A; Kugathasan, S; Denson, LA. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2025; 55:1642-1651.

Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled Trial. Ben-Horin, S; Lahat, A; Ungar, B; Ukashi, O; Yablecovitch, D; Amitai, MM; Haberman, Y; Selinger, L; Talan-Asher, A; Kriger-Sharabi, O; Yanai, H; Dotan, I; Kopylov, U; Eliakim, R. Gastroenterology. 2025; 169:85-93.e3.

Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials. Linggi, B; Azucena, S; Steere, B; Verstockt, B; Alsoud, D; Casero, D; Mcgovern, D; Chan, E; Smith, MI; Ungaro, F; Haberman, Y; Feagan, BG; Jairath, V; Vande Casteele, N. Journal of Crohn's and Colitis. 2025; 19:jjaf068.

Su1990: DESPITE DIFFERENCES IN RECTAL AND ILEAL INVOLVEMENT BETWEEN ULCERATIVE COLITIS AND CROHN’S DISEASE, WE NOTED HIGH SIMILARITY IN MICROBIAL AND METABOLIC SIGNALS IN RECTAL SWAB SAMPLINGS AND MICROBIAL SIGNALS IN THE TERMINAL ILEUM. Naamneh, R; Levhar, N; Hadar, R; Braun, T; Efroni, G; JessulaLevy, D; Granot, M; Nachum, N; Krauthammer, A; Berger, T; Vais, B; Haberman, Y; Amir, A. Gastroenterology. 2025; 169:s-922.

1285: CAN GUT MICROBIAL INDICES SUPPLEMENT ROUTINE HEALTH CHECKUPS? USING GUT INDICES AS INDICATORS FOR CONSUMPTION OF PROCESSED FOODS, ADHERENCE TO THE MEDITERRANEAN DIET, CARDIAC STRESS TEST ERGOMETRY, AND WELL-BEING. Braun, T; Haaronian, O; Hadar, R; Abu-Saad, K; Ziv, A; Efroni, G; Leshem, R; Ziv, R; Abbas-Egabriya, H; Truman, K; Segev, S; Amir, A; Haberman, Y. Gastroenterology. 2025; 169:s-311.

1033: ENHANCING GUT EPITHELIAL INTEGRITY AND REDUCING EPITHELIAL INFLAMMATION THROUGH SUPPLEMENTATION OF FECAL METABOLITES, GUIDED BY NOVEL EX VIVO FUNCTIONAL PRIORITIZATION AND TESTING. Elwahidi, L; Abbas-Egabriya, H; Braun, T; Amir, A; Haberman, Y. Gastroenterology. 2025; 169:s-249.

Su1960: MULTI-OMICS ANALYSIS OF CROHN’S DISEASE TRAJECTORY FROM ACTIVE TO REMISSION REVEALS THAT DURING REMISSION, ALTERED ILEAL ANTI-BACTERIAL EPITHELIAL SIGNALS AND PATHOGENIC MICROBIOME AND METABOLOMICS PERSIST DESPITE NORMALIZING ILEAL IMMUNE SIGNALS. Haberman, Y; Braun, T; Levhar, N; Efroni, G; Hadar, R; JessulaLevy, D; Asher, AT; Ungar, B; Picard, O; Yablecovitch, D; Kopylov, U; Denson, LA; Eliakim, R; Ben-Horin, S; Amir, A. Gastroenterology. 2025; 169:s-908-s-909.

Eicosatetraynoic Acid Regulates Profibrotic Pathways in an Induced Pluripotent Stem Cell-Derived Macrophage-Human Intestinal Organoid Model of Crohn's Disease. Jurickova, I; Dreskin, BW; Angerman, E; Bonkowski, E; Nguyen, J; Villarreal, R; Tominaga, K; Iwasawa, K; Braun, T; Takebe, T; Helmrath, MA; Haberman, Y; Wells, JM; Denson, LA. Journal of Crohn's and Colitis. 2025; 19:jjae139.

P0052 Enhancing gut epithelial integrity and reducing epithelial inflammation through supplementation of fecal metabolites, guided by novel ex vivo functional prioritization and testing. Elwahidi, L; Abbas-Egbariya, H; Braun, T; Amir, A; Haberman, Y. Journal of Crohn's and Colitis. 2025; 19:i408-i410.

DOP025 Subjects sharing bacterial amplicon sequence variants exhibit differences in their IgA and IgG coating of gut bacteria, with enrichment of IgG binding for bacteria typically found in the oral cavity. Levhar, N; Hadar, R; Braun, T; Efroni, G; Ben-Horin, S; Amir, A; Haberman, Y. Journal of Crohn's and Colitis. 2025; 19:i133-i135.